Last reviewed · How we verify
Two IM injections Lenti-HPV-07 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Two IM injections Lenti-HPV-07 (Two IM injections Lenti-HPV-07) — Theravectys S.A..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Two IM injections Lenti-HPV-07 TARGET | Two IM injections Lenti-HPV-07 | Theravectys S.A. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Two IM injections Lenti-HPV-07 CI watch — RSS
- Two IM injections Lenti-HPV-07 CI watch — Atom
- Two IM injections Lenti-HPV-07 CI watch — JSON
- Two IM injections Lenti-HPV-07 alone — RSS
Cite this brief
Drug Landscape (2026). Two IM injections Lenti-HPV-07 — Competitive Intelligence Brief. https://druglandscape.com/ci/two-im-injections-lenti-hpv-07. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab